Back to Agenda
Session 2: Adaptive Pathways and Innovative Medicines Development for Improved Access
Session Chair(s)
Solange Corriol-Rohou, DrMed, MD, PhD
Senior Director, Global Regulatory Affairs & Policy, R&D, Europe
AstraZeneca , France
Speaker(s)
Adaptive Pathways: An HTA Perspective
Jacoline Bouvy, PhD
National Institute for Health and Care Excellence (NICE), United Kingdom
Scientific Adviser, Science Policy and Research Programme
Adaptive Pathways: An Industry’s Perspective
Claudine Sapède, PharmD
NOVARTIS INTERNATIONAL, Switzerland
Director, Global HTA Policy
Richard Barker, PhD
Richard Barker, PhD
Centre for the Advancement of Sustainable Medical Innovation (CASMI), United Kingdom
Founding Director
Adaptive Pathways: A Clinician's Perspective
Rosa Giuliani, MD
European Society for Medical Oncology (ESMO), Switzerland
Consultant in Medical Oncology, S. Camillo-Forlanini Hospital, Italy
Have an account?